O'Neill Julie
Director at ICLR; EVP. Global Operations at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $6.1M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Aug 11, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ICLRICON PLCDirector
- ALEXION PHARMACEUTICALS INCEVP. Global Operations
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ALEXION PHARMACEUTICALS INC41,915 shares
- ICLR915 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualAug 28 2017
Sold 11,160 shares at $140.00 ($1.6M)
O'Neill Julie, EVP. Global Operations
Sold 29.5% of holdings ($5.3M position)26,704 shares left17x usual sizeFiling
- 2 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualSep 5 +8 days
Sold 4,375 shares at $145.44 ($636k)
O'Neill Julie, EVP. Global Operations
Sold 16.4% of holdings ($3.9M position)22,329 shares left6.6x usual sizeFiling
- 3 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 5 +153 days
Sold 2,119 shares at $117.26 ($248k)
O'Neill Julie, EVP. Global Operations
Sold 9.5% of holdings ($2.6M position)20,210 shares left1.9x usual sizeFiling
- 4 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualFeb 8 +3 days
Sold 4,787 shares at $116.31 ($557k)
O'Neill Julie, EVP. Global Operations
Sold 9.7% of holdings ($5.7M position)44,412 shares left3x usual sizeFiling
- 5 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 28 +20 days
Sold 1,625 shares at $119.83 ($195k)
O'Neill Julie, EVP. Global Operations
Sold 3.7% of holdings ($5.3M position)42,787 shares left0.9x usual sizeFiling
- 6 Form 144 notice ICLRNoticeMay 22 +1909 days
Filed to sell 484 shares ($103k)
O'Neill Julie, Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice ICLRNoticeMay 23 +367 days
Filed to sell 490 shares ($155k)
O'Neill Julie, Officer
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale ICLRNo planAug 11 +810 days
Sold 915 shares at $164.29 ($150k)
O'Neill Julie, Director
No 10b5-1 planSold 20.7% of holdings ($728k position)3,515 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | ICLR | Director | Form 4 sale | 915 | $150k | 20.7% | No plan | SEC |
| May 23, 2024 | ICLR | Officer | Form 144 notice | 490 | $155k | Notice | SEC | |
| May 22, 2023 | ICLR | Officer | Form 144 notice | 484 | $103k | Notice | SEC | |
| Feb 28, 2018 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 1,625 | $195k | 3.7% | Plan not stated | SEC |
| Feb 8, 2018 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 4,787 | $557k | 9.7% | Unusual | SEC |
| Feb 5, 2018 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 2,119 | $248k | 9.5% | Plan not stated | SEC |
| Sep 5, 2017 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 4,375 | $636k | 16.4% | Unusual | SEC |
| Aug 28, 2017 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 11,160 | $1.6M | 29.5% | Unusual | SEC |
| Mar 2, 2017 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 651 | $87k | 1.7% | Plan not stated | SEC |
| Feb 28, 2017 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 1,574 | $207k | 4.8% | Plan not stated | SEC |
| Feb 6, 2017 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 2,795 | $351k | 7.9% | Unusual | SEC |
| Sep 2, 2016 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 650 | $82k | 1.8% | Plan not stated | SEC |
| Mar 2, 2016 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 651 | $97k | 1.8% | Plan not stated | SEC |
| Feb 29, 2016 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 663 | $92k | 1.8% | Plan not stated | SEC |
| Feb 8, 2016 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 2,858 | $405k | 8.6% | Unusual | SEC |
| Sep 2, 2015 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 647 | $111k | 2.9% | Plan not stated | SEC |
| Mar 2, 2015 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 6,565 | $1.2M | 22.9% | Plan not stated | SEC |
| Feb 10, 2015 | ALEXION PHARMACEUTICALS INC | EVP. Global Operations | Form 4 sale | 795 | $136k | 3.3% | Plan not stated | SEC |